Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Interpace Biosciences, Inc. Common stock IDXG

Full chart Compare
Set alert

Price alert · IDXG

All alert types
7.00 USD +1.28 (+22.38%)

At closeNov 5, 2026, 4:00 PM EST

5.74 Day range 7.00
0.806 52-week range 7.80
YTD
+469.11%
1 year
+600.00%

Financial health

Altman Z-Score

-5.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 3

Valuation

P/E 0.2×
FY 2016: -4.4×FY 2017: -1.3×FY 2018: -1.8×FY 2019: -0.7×FY 2020: -0.5×FY 2021: -2.1×FY 2022: -0.8×FY 2023: 5.7×FY 2024: 1.9×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/S 0.1×
FY 2016: 2.8×FY 2017: 1.0×FY 2018: 1.0×FY 2019: 0.8×FY 2020: 0.4×FY 2021: 0.7×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.3×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/B 0.2×
FY 2016: 5.6×FY 2017: 0.4×FY 2018: 0.7×FY 2019: 1.4×FY 2020: -0.4×FY 2021: -0.7×FY 2022: -0.1×FY 2023: -0.3×FY 2024: -5.3×FY 2025: 0.2×
FY 2016 5y median -0.3× FY 2025
P/FCF 1.0×
FY 2016: -4.1×FY 2017: -1.0×FY 2018: -2.5×FY 2019: -1.0×FY 2020: -0.8×FY 2021: -3.4×FY 2022: -0.5×FY 2023: 1.4×FY 2024: 3.1×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
EV/EBITDA 0.9×
FY 2016: -22.5×FY 2017: -0.1×FY 2018: -1.9×FY 2019: -1.1×FY 2020: -0.7×FY 2021: -28.8×FY 2022: -6.9×FY 2023: 2.8×FY 2024: 1.9×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
EV/Sales 0.1×
FY 2016: 3.3×FY 2017: 0.1×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 0.5×FY 2021: 0.9×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.1×
FY 2016 5y median 0.3× FY 2025
FCF Yield 100.6%
FY 2016: -24.5%FY 2017: -95.3%FY 2018: -40.5%FY 2019: -101.9%FY 2020: -127.7%FY 2021: -29.4%FY 2022: -181.8%FY 2023: 71.2%FY 2024: 31.8%FY 2025: 100.6%
FY 2016 5y median 31.8% FY 2025

Profitability

Gross Margin 62.3%
FY 2016: 49.2%FY 2017: 53.7%FY 2018: 53.4%FY 2019: 34.0%FY 2020: 33.1%FY 2021: 43.4%FY 2022: 57.3%FY 2023: 59.4%FY 2024: 63.8%FY 2025: 62.3%
FY 2016 5y median 59.4% FY 2025
Operating Margin 10.5%
FY 2016: -49.2%FY 2017: -39.6%FY 2018: -55.3%FY 2019: -99.4%FY 2020: -82.0%FY 2021: -28.4%FY 2022: -12.1%FY 2023: 7.0%FY 2024: 17.3%FY 2025: 10.5%
FY 2016 5y median 7.0% FY 2025
Net Margin 63.5%
FY 2016: -63.7%FY 2017: -76.8%FY 2018: -55.7%FY 2019: -110.6%FY 2020: -80.9%FY 2021: -35.7%FY 2022: -18.4%FY 2023: 2.0%FY 2024: 14.3%FY 2025: 63.5%
FY 2016 5y median 2.0% FY 2025
ROE 109.9%
FY 2016: -127.6%FY 2017: -30.6%FY 2018: -37.0%FY 2019: -204.5%FY 2020: 90.1%FY 2021: 34.8%FY 2022: 9.3%FY 2023: -5.3%FY 2024: -302.3%FY 2025: 109.9%
FY 2016 5y median 9.3% FY 2025
ROIC 14.0%
FY 2016: -24.7%FY 2017: -13.4%FY 2018: -30.3%FY 2019: -44.9%FY 2020: -92.7%FY 2021: -47.8%FY 2022: -80.4%FY 2023: 269.7%FY 2024: 91.6%FY 2025: 14.0%
FY 2016 5y median 14.0% FY 2025
ROA 72.6%
FY 2016: -19.9%FY 2017: -22.8%FY 2018: -25.2%FY 2019: -38.6%FY 2020: -57.4%FY 2021: -38.4%FY 2022: -36.7%FY 2023: 6.2%FY 2024: 45.3%FY 2025: 72.6%
FY 2016 5y median 6.2% FY 2025

Growth (YoY)

Revenue -17.5%
FY 2016: 38.7%FY 2017: 21.5%FY 2018: 37.7%FY 2019: 10.0%FY 2020: 34.5%FY 2021: 27.5%FY 2022: -22.9%FY 2023: 26.3%FY 2024: 16.7%FY 2025: -17.5%
FY 2016 FY 2025
Operating Income -49.6%
FY 2016: 84.1%FY 2017: 2.3%FY 2018: -92.6%FY 2019: -97.5%FY 2020: -11.0%FY 2021: 55.8%FY 2022: 67.3%FY 2023: 173.0%FY 2024: 189.2%FY 2025: -49.6%
FY 2016 FY 2025
EPS (diluted) 122.5%
FY 2016: 26.6%FY 2017: 22.5%FY 2018: 44.1%FY 2019: -64.2%FY 2020: 8.6%FY 2021: 45.1%FY 2022: 61.3%FY 2023: 113.0%FY 2024: 122.2%FY 2025: 122.5%
FY 2016 FY 2025
Free Cash Flow 45.2%
FY 2016: 55.7%FY 2017: -71.1%FY 2018: 40.3%FY 2019: -109.3%FY 2020: 15.4%FY 2021: 43.8%FY 2022: 11.7%FY 2023: 141.4%FY 2024: 13.6%FY 2025: 45.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 0.3×FY 2017: 2.5×FY 2018: 2.1×FY 2019: 0.9×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 0.9×FY 2023: 0.6×FY 2024: 1.1×FY 2025: 1.9×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 1.7×
FY 2016: 0.3×FY 2017: 2.4×FY 2018: 1.9×FY 2019: 0.8×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.5×FY 2024: 1.0×FY 2025: 1.7×
FY 2016 5y median 0.8× FY 2025
Debt / Equity 0.1×
FY 2016: 1.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: -0.2×FY 2021: -0.3×FY 2022: -0.3×FY 2023: -0.7×FY 2024: -2.6×FY 2025: 0.1×
FY 2016 5y median -0.3× FY 2025
Net Debt / EBITDA -0.3×
FY 2016: -3.8×FY 2017: 1.7×FY 2018: 0.7×FY 2019: -0.2×FY 2020: -0.1×FY 2021: -5.6×FY 2022: -5.0×FY 2023: 1.7×FY 2024: 0.5×FY 2025: -0.3×
FY 2016 5y median -0.3× FY 2025
Interest Coverage 24.3×
FY 2016: -3.0×FY 2017: -14.5×FY 2018: -36.6×FY 2019: -54.4×FY 2020: -48.4×FY 2021: -11.3×FY 2022: -3.8×FY 2023: 2.8×FY 2024: 12.3×FY 2025: 24.3×
FY 2016 5y median 2.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31